Viewing StudyNCT00073450



Ignite Creation Date: 2024-05-05 @ 11:31 AM
Last Modification Date: 2024-10-26 @ 9:09 AM
Study NCT ID: NCT00073450
Status: TERMINATED
Last Update Posted: 2015-04-21
First Post: 2003-11-20

Brief Title: Study of Lonafarnib in Patients With Recurrent Squamous Cell Carcinoma of the Head and Neck Study P02530
Sponsor:
Organization: Merck Sharp Dohme LLC

Study Design

Study Type: INTERVENTIONAL
Expanded Access Type Individual: None
Expanded Access Type Intermediate: None
Expanded Access Type Treatment: None
Patient Registry: None
Target Duration: None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention: None
Bio Spec Description: None
Enrollment Count: 15
Enrollment Type: ACTUAL
Design Primary Purpose:
Design Masking:
Phases:
Name
PHASE2
Observational Models:
Time Perspective List:
Who Masked List: